Výsledky vyhledávání - "L, Koenderman"

Akademický článek

Automated, Point-of-Care mobile flow cytometry: Bringing the laboratory to the sample

Autor: B.N. Jukema, T.C. Pelgrim, M. Spoelder, C.C.W.G. Bongers, M.T.E. Hopman, K. Smit, M.H. Rijk, R.P. Venekamp, N. Vrisekoop, L. Koenderman

Publikováno v: Heliyon, Vol 10, Iss 8, Pp e28883- (2024)

Background: Innate effector cells are very responsive to infectious and inflammatory cues found in damaged and inflamed tissues. Their activation is a potential target to assess the state of the immune system. Unfortunately, these cells are very susc

Externí odkaz: https://doaj.org/article/c9caf59f98ad45868b90de66828cd5d2

Zobrazit plný text záznamu

Akademický článek

Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department

Autor: N. L. M. van de Ven, S. H. Bongers, R. Spijkerman, L. Koenderman, L. P. H. Leenen, F. Hietbrink, The COVPACH study group

Publikováno v: BMC Emergency Medicine, Vol 23, Iss 1, Pp 1-10 (2023)

Abstract Introduction Bacterial infections are frequently seen in the emergency department (ED), but can be difficult to distinguish from viral infections and some non-infectious diseases. Common biomarkers such as c-reactive protein (CRP) and white

Externí odkaz: https://doaj.org/article/a9cd9518ceba4d08ae438e09ef9340cb

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Longitudinal assessment of the inflammatory response: The next step in personalized medicine after severe trauma

Autor: E. J. de Fraiture, N. Vrisekoop, L. P. H. Leenen, K. J. P. van Wessem, L. Koenderman, F. Hietbrink

Publikováno v: Frontiers in Medicine, Vol 9 (2022)

Infections in trauma patients are an increasing and substantial cause of morbidity, contributing to a mortality rate of 5–8% after trauma. With increased early survival rates, up to 30–50% of multitrauma patients develop an infectious complicatio

Externí odkaz: https://doaj.org/article/771e715f049c4921903c9fd6127cafd8

Zobrazit plný text záznamu

Akademický článek

Neutrophil and Eosinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease

Autor: B. N. Jukema, K. Smit, M. T. E. Hopman, C. C. W. G. Bongers, T. C. Pelgrim, M. H. Rijk, T. N. Platteel, R. P. Venekamp, D. L. M. Zwart, F. H. Rutten, L. Koenderman

Publikováno v: Frontiers in Allergy, Vol 3 (2022)

IntroductionNeutrophil and eosinophil activation and its relation to disease severity has been understudied in primary care patients with COVID-19. In this study, we investigated whether the neutrophil and eosinophil compartment were affected in prim

Externí odkaz: https://doaj.org/article/1d8fd347f90541b588bb9f6edd0f1972

Zobrazit plný text záznamu

Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases

Autor: B. Hilvering, L. Koenderman

Publikováno v: Respiratory Medicine, 207:107094. W.B. Saunders Ltd
Hilvering, B & Koenderman, L 2023, ' Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases ', Respiratory Medicine, vol. 207, 107094 . https://doi.org/10.1016/j.rmed.2022.107094

Eosinophil associated diseases have gained much attention recently because of the introduction of specific eosinophil targeted therapies. These diseases range from acute parasitic infections to chronic inflammatory diseases such as eosinophilic asthm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb4cce122cc3590888b5a7382c98b96
https://doi.org/10.1016/j.rmed.2022.107094

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.

Autor: Theresa Guhr, Judith Bloem, Ninotska I L Derksen, Manfred Wuhrer, Anky H L Koenderman, Rob C Aalberse, Theo Rispens

Publikováno v: PLoS ONE, Vol 6, Iss 6, p e21246 (2011)

Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use in immune modulating therapies such as treatment of immune thrombocytopenic purpura high doses of IVIg are required. It has been suggested that only

Externí odkaz: https://doaj.org/article/7a8539f4879f4dfc9bbf2e1d862e9518

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání